CS logo
small CS logo
Massachusetts General Hospital Schizophrenia Program

Boston, Massachusetts, United States

About Massachusetts General Hospital Schizophrenia Program


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Massachusetts General Hospital Schizophrenia Program


During the past decade, Massachusetts General Hospital Schizophrenia Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital Schizophrenia Program" #1 collaborator was "National Alliance for Research on Schizophrenia and Depression" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator and "Stanley Medical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Massachusetts General Hospital Schizophrenia Program


According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital Schizophrenia Program" are "Schizophrenia" (2 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital Schizophrenia Program" in a lesser frequency.

Clinical Trials Intervention Types at Massachusetts General Hospital Schizophrenia Program


Most popular intervention types in "Massachusetts General Hospital Schizophrenia Program" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aripiprazole" (1 trials), "Placebo" (1 trials), "placebo" (1 trials) and "rosiglitazone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Massachusetts General Hospital Schizophrenia Program


The vast majority of trials in "Massachusetts General Hospital Schizophrenia Program" are 2 trials for "All" genders.

Clinical Trials Status at Massachusetts General Hospital Schizophrenia Program


Currently, there are NaN active trials in "Massachusetts General Hospital Schizophrenia Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Massachusetts General Hospital Schizophrenia Program, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Massachusetts General Hospital Schizophrenia Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".